Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GRI CVE:SVS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRIGRI Bio$2.03$2.42$2.03▼$80.36$3.60M-1.2240,605 shs21,569 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRIGRI Bio0.00%-8.76%-20.39%-12.12%-95.17%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGRIGRI Bio$2.03$2.42$2.03▼$80.36$3.60M-1.2240,605 shs21,569 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGRIGRI Bio0.00%-8.76%-20.39%-12.12%-95.17%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGRIGRI Bio 2.33Hold$1,008.0049,555.17% UpsideSVSSolarvest BioEnergy 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TPFG, GRI, SVS, and LOK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2026GRIGRI Bio Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGRIGRI BioN/AN/AN/AN/A$4.16 per shareN/ASVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGRIGRI Bio-$11.96M-$235.02N/AN/AN/AN/A-199.52%-143.23%5/21/2026 (Estimated)SVSSolarvest BioEnergy-C$2.26M-C$0.04N/AN/AN/AN/AN/A-143.12%N/ALatest TPFG, GRI, SVS, and LOK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2026Q1 2026GRIGRI Bio-$3.74N/AN/AN/AN/AN/A5/13/2026Q1 2026GRIGRI Bio-$1.6050-$1.61-$0.0050-$1.61N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGRIGRI Bio$1.9194.09%N/AN/A N/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGRIGRI BioN/A14.2014.21SVSSolarvest BioEnergyN/AN/A0.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGRIGRI Bio33.95%SVSSolarvest BioEnergyN/AInsider OwnershipCompanyInsider OwnershipGRIGRI Bio8.73%SVSSolarvest BioEnergy15.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGRIGRI Bio11.77 million1.62 millionNot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableTPFG, GRI, SVS, and LOK HeadlinesRecent News About These CompaniesSolarvest lands RM1.06bil LSS5+ dealApril 24, 2026 | thestar.com.myTSolarvest clinches RM1bil LSS5+ dealApril 24, 2026 | thestar.com.myTSolarvest 3Q net profit jumps 46% to RM21milFebruary 24, 2026 | thestar.com.myTSolarvest earnings trajectory remains intactFebruary 8, 2026 | thestar.com.myTSolarvest says module prices 'locked-in' amid rising costsFebruary 5, 2026 | thestar.com.myTSolarvest growth prospects intactJanuary 22, 2026 | thestar.com.myTThere May Be Underlying Issues With The Quality Of Solarvest Holdings Berhad's (KLSE:SLVEST) EarningsNovember 27, 2025 | finance.yahoo.comSolarvest secures RM320mil EPCC PV jobNovember 20, 2025 | thestar.com.myTSolarvest quarterly net profit doublesNovember 19, 2025 | thestar.com.myTSolarvest's net profit doubles y-o-y to RM18.73mil in 2QNovember 19, 2025 | thestar.com.myTPrivate placement to bolster SolarvestOctober 22, 2025 | thestar.com.myTSolarvest shares fall after announcing RM254.1mil private placement planOctober 22, 2025 | thestar.com.myTSolarvest's private placement to bolster growth momentumOctober 22, 2025 | thestar.com.myTKINETA, Solarvest team up for greener EV chargingOctober 21, 2025 | paultan.orgPKineta and Solarvest partner on clean energy and solar EV charging solutionsOctober 17, 2025 | autobuzz.myASolarvest And Kineta Enter Into PartnershipOctober 17, 2025 | lowyat.netLMalakoff appoints Solarvest for LSS Petra 5+ solar project in MalaysiaOctober 17, 2025 | power-technology.comPMalakoff appoints Solarvest as EPCC contractor for 470MW projectOctober 16, 2025 | thestar.com.myTSolarvest latest quota win to add RM300mil to coffersOctober 7, 2025 | thestar.com.myTSolarvest and Press Metal special purpose vehicle to develop solar plant in MalaysiaOctober 6, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines1 Stock Is Powering the AI Boom and the Next Farm SupercycleBy Jeffrey Neal Johnson | April 22, 2026The USMCA Review Is Coming: 3 Border-Sensitive Stocks to WatchBy Chris Markoch | May 8, 2026Astera Labs: The Tollbooth for AI's Traffic JamBy Jeffrey Neal Johnson | April 23, 2026Chipotle Stock Just Hit Bottom—Is a Breakout Next?By Thomas Hughes | April 30, 20263 Agriculture Stocks to Buy as Food Inflation Stays Elevated in 2026By Chris Markoch | April 20, 2026TPFG, GRI, SVS, and LOK Company DescriptionsGRI Bio NASDAQ:GRI$2.03 0.00 (0.00%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$2.07 +0.04 (+1.77%) As of 06:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.Solarvest BioEnergy CVE:SVSC$0.02 0.00 (0.00%) As of 09/5/2023Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In Robinhood, SoFi, and Webull Are Telling Very Different Stories Viking Sails to All-Time Highs—Fundamentals Signal More to Come Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
